Bio Platforms

EXCLUSIVE ONLINE CONTENT

6/26/2019

Novavax & Catalent Biologics Enter Strategic Partnership

Novavax, Inc. and Catalent Biologics’ Paragon Gene Therapy unit recently announced an arrangement under which Paragon Gene Therapy will assume the leases to two Novavax product development and manufacturing facilities, giving it immediate access to……..

6/25/2019

From ASCO 2019: TILs a Cause for Hope in Melanoma, Cervical & Breast Cancers

As the Spring heat made the light dance around the skin of the largest convention center in America, winners emerged from ASCO last month. One of the most significant announcements (from Iovance Biotherapeutics Inc.) were two first-in-man studies of adoptive T cell therapy (ACT) in patients with melanoma and cervical cancer which had failed to respond to other treatments.